• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pathogenicity of SARS-CoV-2 Omicron BA.1.1 in hamsters.严重急性呼吸综合征冠状病毒2型奥密克戎BA.1.1在仓鼠中的致病性。
EBioMedicine. 2022 Jun;80:104035. doi: 10.1016/j.ebiom.2022.104035. Epub 2022 Apr 28.
2
Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.奥密克戎（R346K）变异株在叙利亚仓鼠中的致病性及其与不同关切变异株的交叉中和作用。
EBioMedicine. 2022 May;79:103997. doi: 10.1016/j.ebiom.2022.103997. Epub 2022 Apr 8.
3
Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian Hamsters.与早期严重急性呼吸综合征冠状病毒 2 D614G 变体相比，奥密克戎 BA.1 和 BA.2 亚谱系在叙利亚仓鼠中致病性和传播潜力降低。
J Infect Dis. 2023 May 12;227(10):1143-1152. doi: 10.1093/infdis/jiac276.
4
Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters.感染、病理学和干扰素对 SARS-CoV-2 奥密克戎 BA.1 变异株在幼年、成年和老年叙利亚仓鼠中的作用。
Cell Mol Immunol. 2022 Dec;19(12):1392-1399. doi: 10.1038/s41423-022-00923-9. Epub 2022 Oct 18.
5
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates.SARS-CoV-2 奥密克戎 BA.2.75 临床分离株的特征。
Nat Commun. 2023 Mar 23;14(1):1620. doi: 10.1038/s41467-023-37059-x.
6
Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.原型和 BA.5 蛋白纳米颗粒疫苗可预防叙利亚仓鼠感染奥密克戎 BA.5 变异株。
J Virol. 2024 Mar 19;98(3):e0120623. doi: 10.1128/jvi.01206-23. Epub 2024 Feb 2.
7
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents.啮齿动物中新型冠状病毒奥密克戎BA.4和BA.5毒株的特征分析
Nature. 2022 Dec;612(7940):540-545. doi: 10.1038/s41586-022-05482-7. Epub 2022 Nov 2.
8
Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.奥密克戎变异株再次感染对先前感染仓鼠的影响。
J Virol. 2023 Jan 31;97(1):e0136622. doi: 10.1128/jvi.01366-22. Epub 2023 Jan 12.
9
In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants.D614G、Delta 和奥密克戎 BA.1 SARS-CoV-2 变体之间神经毒力的体外和体内差异。
Acta Neuropathol Commun. 2022 Sep 5;10(1):124. doi: 10.1186/s40478-022-01426-4.
10
Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters.叙利亚仓鼠中新冠病毒奥密克戎BA.1毒株的空气传播减少
PLoS Pathog. 2022 Dec 2;18(12):e1010970. doi: 10.1371/journal.ppat.1010970. eCollection 2022 Dec.

引用本文的文献

1
Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review.新冠疫情急性期过渡期间的关键考量因素：一项叙述性综述
Vaccines (Basel). 2023 Sep 19;11(9):1502. doi: 10.3390/vaccines11091502.
2
A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs.对新出现的奥密克戎（B.1.1.529）变体的突变情况进行全面分析，并与 VOCs 和 VOIs 的突变进行比较。
Geroscience. 2022 Oct;44(5):2393-2425. doi: 10.1007/s11357-022-00631-2. Epub 2022 Aug 22.
3
Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths.概述严重急性呼吸综合征冠状病毒2（SARS-CoV-2）及其主要变体的特征：现状与未来发展路径
J Pers Med. 2022 Jun 18;12(6):995. doi: 10.3390/jpm12060995.

本文引用的文献

1
Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark.丹麦关注的 SARS-CoV-2 奥密克戎变体 BA.1 和 BA.2 亚变体的家庭传播。
Nat Commun. 2022 Sep 30;13(1):5760. doi: 10.1038/s41467-022-33498-0.
2
Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.奥密克戎（R346K）变异株在叙利亚仓鼠中的致病性及其与不同关切变异株的交叉中和作用。
EBioMedicine. 2022 May;79:103997. doi: 10.1016/j.ebiom.2022.103997. Epub 2022 Apr 8.
3
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.比较分析英国住院和死亡风险与 SARS-CoV-2 奥密克戎（B.1.1.529）和德尔塔（B.1.617.2）变异株的关系：一项队列研究。
Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16.
4
Antibody evasion properties of SARS-CoV-2 Omicron sublineages.SARS-CoV-2 奥密克戎亚谱系的抗体逃逸特性。
Nature. 2022 Apr;604(7906):553-556. doi: 10.1038/s41586-022-04594-4. Epub 2022 Mar 3.
5
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.奥密克戎变异株的融合性和致病性减弱。
Nature. 2022 Mar;603(7902):700-705. doi: 10.1038/s41586-022-04462-1. Epub 2022 Feb 1.
6
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron.奥密克戎变异株 B.1.1.529 对 SARS-CoV-2 的复制和致病性减弱。
Nature. 2022 Mar;603(7902):693-699. doi: 10.1038/s41586-022-04442-5. Epub 2022 Jan 21.
7
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters.新冠病毒奥密克戎变异株在小鼠和仓鼠中引起轻症疾病。
Nature. 2022 Mar;603(7902):687-692. doi: 10.1038/s41586-022-04441-6. Epub 2022 Jan 21.
8
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.南非 SARS-CoV-2 奥密克戎变异株的快速流行扩张。
Nature. 2022 Mar;603(7902):679-686. doi: 10.1038/s41586-022-04411-y. Epub 2022 Jan 7.
9
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.奥密克戎变异株对 SARS-CoV-2 表现出明显的抗体逃逸。
Nature. 2022 Feb;602(7898):676-681. doi: 10.1038/s41586-021-04388-0. Epub 2021 Dec 23.

Pathogenicity of SARS-CoV-2 Omicron BA.1.1 in hamsters.

作者信息

Chan Jasper Fuk-Woo, Chu Hin

机构信息

State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China; Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.

State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China; Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.

出版信息

EBioMedicine. 2022 Jun;80:104035. doi: 10.1016/j.ebiom.2022.104035. Epub 2022 Apr 28.

DOI:10.1016/j.ebiom.2022.104035
PMID:35490459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9046704/
Abstract
摘要